A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope

S. S. Lane, B. D. Kuppermann, I. H. Fine, M. B. Hamill, J. F. Gordon, R. S. Chuck, R. S. Hoffman, M. Packer, D. D. Koch

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

Purpose To evaluate the safety and preliminary efficacy of a novel visual prosthetic device, the Implantable Miniature Telescope, IMT (by Dr Isaac Lipshitz) (IMT), in a phase I trial in patients with significant bilateral central vision impairment from late-stage age-related macular degeneration (AMD). The IMT is designed to reduce the relative size of the scotoma by rendering enlarged (threefold) central visual field images over the central and peripheral retina. Design Prospective, multicenter, open-label clinical trial. Methods In this prospective, multicenter phase I trial, 14 patients aged 60 or older with bilateral geographic atrophy or disciform scar AMD, cataract, and best-corrected visual acuity (BCVA) between 20/80 and 20/400 had an IMT implanted in one eye. Distance and near BCVA, endothelial cell density, and quality of life, measured as activities of daily life (ADL), were evaluated preoperatively and postoperatively. Results At 12 months, 10 (77%) of 13 patients gained 2 more lines of either distance or near BCVA, and eight (62%) of 13 patients gained 3 or more lines in either distance or near BCVA. Mean endothelial cell density decreased by 13%. All adverse events resolved without sequelae. ADL scores improved in the majority of patients. Conclusion The results of this phase I trial support further evaluation of the IMT in a larger study population with late-stage AMD. A phase II/III trial is in progress.

Original languageEnglish (US)
Pages (from-to)993-1001
Number of pages9
JournalAmerican Journal of Ophthalmology
Volume137
Issue number6
DOIs
Publication statusPublished - Jun 1 2004
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Ophthalmology

Cite this